Phillip Monk

1. Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial
   2020/11/12 by Phillip Monk, Phillip D Monk, Richard J Marsden +47 · 1 citation
   Dentistry · Medicine · #COVID-19 Clinical Research Studies #Dental Research and COVID-19 #Infection Control and Ventilation